Mallinckrodt Expands Portfolio
H.P. Acthar® Gel (repository corticotropin injection) is now part of Mallinckrodt’s new Autoimmune and Rare Diseases business.
We strive to make the complex simple.
The common thread critical to our past and future success is our strong ability to master and manage complexity.
Commitment to the Community
From our headquarters to operating sites around the world, Mallinckrodt's philanthropic activities strive to advance society in meaningful ways.
The Mallinckrodt Story
Building our future on a heritage of more than 145 years